• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LAPTM5 在疾病中的功能和作用机制。

The function and mechanism of LAPTM5 in diseases.

机构信息

Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

Department of Critical Care Medicine, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

出版信息

Biomed Pharmacother. 2024 Sep;178:117237. doi: 10.1016/j.biopha.2024.117237. Epub 2024 Aug 2.

DOI:10.1016/j.biopha.2024.117237
PMID:39096616
Abstract

The Lysosomal Protein Transmembrane 5 (LAPTM5) is a lysosomal transmembrane protein preferentially expressed in hematopoietic cells. The human LAPTM5 gene is located at position 1p34 and extends approximately 25 kb. Its protein includes five transmembrane domains, three PY motifs, and one UIM. The PY and UIM motifs can interact with various substrates, mediating sorting of proteins from Golgi to lysosome and subsequently participating in intracellular substrate transport and lysosomal stability regulation. Overexpression of LAPTM5 can induce lysosomal cell death (LCD), although the integrity of LAPTM5 protein is necessary for maintaining lysosome stability. Furthermore, LAPTM5 plays a role in autophagy activation during disease processes and has been confirmed to be closely associated with the regulation of immunity and inflammation. Therefore, LAPTM5 regulates a wide range of physiological processes and is involved in various diseases. This article summarizes the characteristics of the LAPTM5 gene and protein structure and provides a comprehensive review of the mechanisms involved in cell death, autophagy, immunity, and inflammation regulation. It emphasizes the significance of LAPTM5 in the clinical prevention and treatment of cardiovascular diseases, immune system disorders, viral infections, cancer, and other diseases, which could provide new therapeutic ideas and targets for human diseases.

摘要

溶酶体跨膜蛋白 5(LAPTM5)是一种优先在造血细胞中表达的溶酶体跨膜蛋白。人类 LAPTM5 基因位于 1p34 位置,大约 25kb 长。其蛋白包含五个跨膜结构域、三个 PY 基序和一个 UIM。PY 和 UIM 基序可以与各种底物相互作用,介导蛋白质从高尔基体到溶酶体的分拣,随后参与细胞内底物运输和溶酶体稳定性调节。LAPTM5 的过表达可诱导溶酶体细胞死亡(LCD),尽管 LAPTM5 蛋白的完整性对于维持溶酶体稳定性是必要的。此外,LAPTM5 在疾病过程中参与自噬的激活,并已被证实与免疫和炎症的调节密切相关。因此,LAPTM5 调节广泛的生理过程并参与各种疾病。本文总结了 LAPTM5 基因和蛋白结构的特征,并对细胞死亡、自噬、免疫和炎症调节的相关机制进行了全面综述。强调了 LAPTM5 在心血管疾病、免疫系统紊乱、病毒感染、癌症等疾病的临床预防和治疗中的重要性,为人类疾病的治疗提供了新的思路和靶点。

相似文献

1
The function and mechanism of LAPTM5 in diseases.LAPTM5 在疾病中的功能和作用机制。
Biomed Pharmacother. 2024 Sep;178:117237. doi: 10.1016/j.biopha.2024.117237. Epub 2024 Aug 2.
2
Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination.LAPTM5转运至溶酶体需要与泛素连接酶Nedd4结合,但不需要LAPTM5泛素化。
J Cell Biol. 2006 Nov 20;175(4):631-45. doi: 10.1083/jcb.200603001.
3
regulates the integrity of lysosomal membrane by hnRNP K-stabilized transcript and promotes cell survival.通过 hnRNP K 稳定的转录本调节溶酶体膜的完整性,并促进细胞存活。
Proc Natl Acad Sci U S A. 2022 Feb 1;119(5). doi: 10.1073/pnas.2110428119.
4
Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas.溶酶体相关蛋白多跨膜 5 基因(LAPTM5)与神经母细胞瘤的自发消退有关。
PLoS One. 2009 Sep 29;4(9):e7099. doi: 10.1371/journal.pone.0007099.
5
Down-regulation of LAPTM5 in human cancer cells.人癌细胞中LAPTM5的下调
Oncotarget. 2016 May 10;7(19):28320-8. doi: 10.18632/oncotarget.8614.
6
LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.LAPTM5 蛋白是巨噬细胞中促炎信号通路的正向调节剂。
J Biol Chem. 2012 Aug 10;287(33):27691-702. doi: 10.1074/jbc.M112.355917. Epub 2012 Jun 25.
7
Ectopic overexpression of LAPTM5 results in lysosomal targeting and induces Mcl-1 down-regulation, Bak activation, and mitochondria-dependent apoptosis in human HeLa cells.LAPTM5的异位过表达导致溶酶体靶向,并诱导人宫颈癌细胞系HeLa细胞中Mcl-1下调、Bak激活和线粒体依赖性凋亡。
PLoS One. 2017 May 2;12(5):e0176544. doi: 10.1371/journal.pone.0176544. eCollection 2017.
8
A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins.Nedd4 泛素连接酶在 LAPTM4 蛋白的膜分选中的作用。
PLoS One. 2011;6(11):e27478. doi: 10.1371/journal.pone.0027478. Epub 2011 Nov 11.
9
LAPTM5 promotes lysosomal degradation of intracellular CD3ζ but not of cell surface CD3ζ.LAPTM5促进细胞内CD3ζ的溶酶体降解,但不促进细胞表面CD3ζ的溶酶体降解。
Immunol Cell Biol. 2014 Jul;92(6):527-34. doi: 10.1038/icb.2014.18. Epub 2014 Mar 18.
10
Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.LAPTM5的下调抑制膀胱癌细胞的细胞增殖和活力,诱导细胞周期停滞于G0/G1期。
Int J Oncol. 2017 Jan;50(1):263-271. doi: 10.3892/ijo.2016.3788. Epub 2016 Dec 5.

引用本文的文献

1
HIV-1 latency: From acquaintance to confidant.HIV-1潜伏:从相识到知己。
J Virus Erad. 2025 May 20;11(2):100597. doi: 10.1016/j.jve.2025.100597. eCollection 2025 Jun.
2
LINC02888 promotes HGSOC progression and immune evasion via PPIB-mediated stabilization of LAPTM5 mRNA and inhibition of RIG-I-like receptor signaling.LINC02888通过PPIB介导的LAPTM5 mRNA稳定和对RIG-I样受体信号传导的抑制促进高级别浆液性卵巢癌进展和免疫逃逸。
J Transl Med. 2025 Jun 11;23(1):640. doi: 10.1186/s12967-025-06650-9.
3
Transcriptomic and Metabolomic Analysis Reveals the Impact of Autophagy Regulation on Purine Content in Mutton.
转录组学和代谢组学分析揭示自噬调控对羊肉嘌呤含量的影响。
Foods. 2025 Feb 20;14(5):718. doi: 10.3390/foods14050718.
4
Identification of crucial genes for polycystic ovary syndrome and atherosclerosis through comprehensive bioinformatics analysis and machine learning.通过综合生物信息学分析和机器学习确定多囊卵巢综合征和动脉粥样硬化的关键基因。
Int J Gynaecol Obstet. 2025 Jul;170(1):312-325. doi: 10.1002/ijgo.70014. Epub 2025 Feb 21.
5
LAPTM5 Confers the Resistance to Venetoclax via Promoting the Autophagosome-Lysosome Fusion in Multiple Myeloma.LAPTM5通过促进多发性骨髓瘤中的自噬体-溶酶体融合赋予对维奈托克的抗性。
J Cell Mol Med. 2025 Jan;29(1):e70331. doi: 10.1111/jcmm.70331.